Altered bone matrix mineralization in a patient with Rett syndrome.
Rett syndrome (RTT) is a common X-linked neurodevelopmental disorder caused by mutations in the coding region of methyl-CpG-binding 2 (MECP2) gene. Patients with RTT have a low bone mineral density and increased risk of fracture. However, very little is known if bone matrix mineralization is altered in RTT. A 17-year-old girl with a classical form of RTT with a heterozygous nonsense mutation in exon 3 in the MECP2-gene was treated in our hospital. Her femoral neck BMD is 43.3% below the 3rd percentile when compared to age and sex-matched controls. She underwent surgery for correction of her scoliosis, which provided a unique opportunity to obtain bone tissue to study bone matrix mineralization (Bone Mineralization Density Distribution-BMDD) using quantitative backscattered electron imaging (qBEI) and histomorphometry. BMDD outcomes were compared to recently published normative reference data for young individuals. qBEI analysis showed a significant shift to lower matrix mineralization despite histomorphometric indices indicate a low bone turnover. There was a reduction in CaMean (-7.92%) and CaPeak (-3.97%), which describe the degree of mineralization. Furthermore the fraction of low mineralized matrix (CaLow: +261.84%) was dramatically increased, which was accompanied with an increase in the heterogeneity of mineralization (CaWidth: +86.34%). Our findings show a significantly altered bone matrix mineralization of a typical patient with RTT. This may partly explain the low bone density seen in these patients. These results also warrant further studies on the molecular role of MECP2 in bone matrix mineralization.
Hofstaetter
Jochen G
JG
Department of Orthopaedic Surgery, Vienna General Hospital, Medical University of Vienna, Vienna, Austria. jochen.hofstaetter@meduniwien.ac.at
Roetzer
Katharina M
KM
Krepler
Petra
P
Nawrot-Wawrzyniak
Kamilla
K
Schwarzbraun
Thomas
T
Klaushofer
Klaus
K
Roschger
Paul
P
D000293:Adolescent; D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000235:genetics; D001857:Bone Matrix / Q000502:physiology*; D002113:Calcification, Physiologic / Q000502:physiology*; D005260:Female; D006801:Humans; D051783:Methyl-CpG-Binding Protein 2 / Q000235:genetics; D015518:Rett Syndrome / Q000235:genetics / Q000473:pathology / Q000503:physiopathology
D015415:Biomarkers; D051783:Methyl-CpG-Binding Protein 2